CD274 and non-small cell lung carcinoma: PANTANO F., et al. conducted a comprehensive analysis of EV-associated miRNAs produced by cancer cells and identified EV-miR-625-5p as a novel independent biomarker of response and survival in patients with NSCLC treated with ICIs, particularly in those with PD-L1 expression ≥50%.